GSK has acquired RAPT Therapeutics
Further information can be found in the latest press release.
COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
April 15, 2025
« back to news page
You are leaving RAPT.com to go to the eczema clinical trial study site.
